Latest News about MRTX
Recent news which mentions MRTX
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
August 26, 2021
From Benzinga
My 2019 Report Card: Up 319%
August 15, 2021
From Motley Fool
3 Best Biotech Stocks To Buy for Upcoming Catalysts
August 12, 2021
From InvestorPlace
Mirati's KRAS Inhibitor Receives FDA Breakthrough Tag For Lung Cancer Harboring KRAS Mutation
June 25, 2021
Tickers
MRTX
From Benzinga
From Benzinga
20 Stocks Moving in Friday's Pre-Market Session
June 25, 2021
From Benzinga
A Peek Into The Markets: US Stock Futures Up Following Thursday's Rally; Nike Posts Upbeat Results
June 25, 2021
From Benzinga
7 Stocks Moving In Thursday's After-Hours Session
June 24, 2021
From Benzinga
14 Biotech Stocks To Watch Over The Next 6 Months
June 23, 2021
From Benzinga
From Benzinga
This Is Why Amgen's New Cancer Drug Could Be Huge
June 02, 2021
From Motley Fool
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Monday
May 17, 2021
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Monday
May 10, 2021
From Benzinga
This Is How Amgen Avoided a Catastrophic Q1 Update
April 29, 2021
From Motley Fool
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
April 10, 2021
From Benzinga
This 2020 Biotech IPO Is Poised to Break Out in 2021
April 02, 2021
From Motley Fool
From InvestorPlace
7 Pharmaceutical Stocks Working on Their Next Blockbuster
March 12, 2021
From InvestorPlace
Better Buy: iShares Russell 2000 Growth ETF vs Schwab U.S. Small-Cap ETF
February 28, 2021
From Motley Fool
Why Turning Point Is Turning Heads
February 23, 2021
From Motley Fool
Why Cardiff Oncology Ran Up 1,350% in 2020
January 31, 2021
From Motley Fool
15 Stocks Moving In Tuesday's After-Hours Session
January 12, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 14, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
December 11, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 10, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.